X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs PIRAMAL ENTERPRISES - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD PIRAMAL ENTERPRISES BIOCON LTD/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 96.7 9.6 1,009.3% View Chart
P/BV x 8.2 1.7 496.6% View Chart
Dividend Yield % 0.1 1.0 14.3%  

Financials

 BIOCON LTD   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
PIRAMAL ENTERPRISES
Mar-18
BIOCON LTD/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,1883,083 38.5%   
Low Rs3051,902 16.0%   
Sales per share (Unadj.) Rs68.7589.7 11.7%  
Earnings per share (Unadj.) Rs7.6284.0 2.7%  
Cash flow per share (Unadj.) Rs14.0310.5 4.5%  
Dividends per share (Unadj.) Rs1.0025.00 4.0%  
Dividend yield (eoy) %0.11.0 13.4%  
Book value per share (Unadj.) Rs86.31,467.0 5.9%  
Shares outstanding (eoy) m600.00180.27 332.8%   
Bonus/Rights/Conversions ISIS-  
Price / Sales ratio x10.94.2 257.0%   
Avg P/E ratio x98.98.8 1,126.5%  
P/CF ratio (eoy) x53.48.0 665.7%  
Price / Book Value ratio x8.61.7 508.8%  
Dividend payout %13.28.8 150.4%   
Avg Mkt Cap Rs m447,900449,332 99.7%   
No. of employees `0006.16.8 89.9%   
Total wages/salary Rs m9,31119,881 46.8%   
Avg. sales/employee Rs Th6,705.815,535.6 43.2%   
Avg. wages/employee Rs Th1,514.22,905.4 52.1%   
Avg. net profit/employee Rs Th736.97,482.5 9.8%   
INCOME DATA
Net Sales Rs m41,234106,310 38.8%  
Other income Rs m2,0622,595 79.5%   
Total revenues Rs m43,296108,906 39.8%   
Gross profit Rs m8,29151,599 16.1%  
Depreciation Rs m3,8514,773 80.7%   
Interest Rs m61529,783 2.1%   
Profit before tax Rs m5,88719,638 30.0%   
Minority Interest Rs m2132,801 7.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569-28,764 -5.5%   
Profit after tax Rs m4,53151,203 8.8%  
Gross profit margin %20.148.5 41.4%  
Effective tax rate %26.7-146.5 -18.2%   
Net profit margin %11.048.2 22.8%  
BALANCE SHEET DATA
Current assets Rs m41,486118,154 35.1%   
Current liabilities Rs m21,413462,260 4.6%   
Net working cap to sales %48.7-323.7 -15.0%  
Current ratio x1.90.3 758.0%  
Inventory Days Days6427 240.7%  
Debtors Days Days9447 202.4%  
Net fixed assets Rs m50,661113,727 44.5%   
Share capital Rs m3,000361 832.2%   
"Free" reserves Rs m48,808264,093 18.5%   
Net worth Rs m51,808264,454 19.6%   
Long term debt Rs m17,898242,206 7.4%   
Total assets Rs m99,897726,834 13.7%  
Interest coverage x10.61.7 637.1%   
Debt to equity ratio x0.30.9 37.7%  
Sales to assets ratio x0.40.1 282.2%   
Return on assets %5.211.1 46.2%  
Return on equity %8.719.4 45.2%  
Return on capital %9.610.3 93.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05815,110 79.8%   
Fx outflow Rs m7,3484,298 171.0%   
Net fx Rs m4,71010,813 43.6%   
CASH FLOW
From Operations Rs m6,621-159,666 -4.1%  
From Investments Rs m-6,840-17,677 38.7%  
From Financial Activity Rs m-2,397186,503 -1.3%  
Net Cashflow Rs m-2,6129,364 -27.9%  

Share Holding

Indian Promoters % 40.4 52.9 76.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.0 210.0%  
FIIs % 10.7 26.6 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 16.5 120.6%  
Shareholders   109,995 93,274 117.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare BIOCON LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Related Views on News

BIOCON LTD Surges by 5%; BSE HEALTHCARE Index Up 1.8% (Market Updates)

Sep 25, 2018 | Updated on Sep 25, 2018

BIOCON LTD share price has surged by 5% and its current market price is Rs 701. The BSE HEALTHCARE is up by 1.8%. The top gainers in the BSE HEALTHCARE Index is BIOCON LTD (up 5.0%). The top losers are ABBOTT INDIA and J.B.CHEMICALS (down 0.3%).

PIRAMAL ENTERPRISES Plunges by 5%; BSE HEALTHCARE Index Up 0.9% (Market Updates)

Sep 25, 2018 | Updated on Sep 25, 2018

PIRAMAL ENTERPRISES share price has plunged by 5% and its current market price is Rs 2,565. The BSE HEALTHCARE is up by 0.9%. The top gainers in the BSE HEALTHCARE Index are BIOCON LTD (up 3.3%) and BLISS GVS PHARMA (up 3.0%). The top losers is PIRAMAL ENTERPRISES (down 5.1%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Sep 25, 2018 03:37 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS